{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:06:32Z","timestamp":1789545992617,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703584"],"award-info":[{"award-number":["81703584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011091"],"award-info":[{"award-number":["2023A1515011091"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010196"],"award-info":[{"award-number":["2025A1515010196"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515220166"],"award-info":[{"award-number":["2022A1515220166"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bonr.2026.101942","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:50:36Z","timestamp":1787410236000},"page":"101942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Blockade of NLRP3 alleviates systemic lupus erythematosus-induced osteoporosis through dual modulation of osteogenesis and osteoclastogenesis"],"prefix":"10.1016","volume":"30","author":[{"given":"Feifu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.bonr.2026.101942_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235867","article-title":"Osteoporosis in rheumatic diseases","volume":"20","author":"Adami","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bonr.2026.101942_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 Inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bonr.2026.101942_bb0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.clinthera.2011.10.008","article-title":"Denosumab for the reduction of bone loss in postmenopausal osteoporosis: a review","volume":"33","author":"Bridgeman","year":"2011","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.bonr.2026.101942_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00223-017-0322-z","article-title":"Bone disease in connective tissue disease\/systemic lupus erythematosus","volume":"102","author":"Bultink","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2026.101942_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112382","article-title":"NLRP3 blockade by MCC950 suppressed osteoclastogenesis via NF-\u03baB\/c-Fos\/NFATc1 signal pathway and alleviated bone loss in diabetes mellitus","volume":"594","author":"Cai","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.bonr.2026.101942_bb0030","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","article-title":"NOD-like receptors in autoimmune diseases","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.bonr.2026.101942_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70094","article-title":"Zoledronic acid inhibits lipopolysaccharide-induced osteoclastogenesis by suppressing macrophage NLRP3-mediated autophagy pathway","volume":"12","author":"Cheng","year":"2024","journal-title":"Immun, Inflamm, Dis"},{"key":"10.1016\/j.bonr.2026.101942_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"3","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bonr.2026.101942_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"6","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5184","key":"10.1016\/j.bonr.2026.101942_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bonr.2026.101942_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.014","article-title":"Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation","volume":"103","author":"Guo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0060","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bonr.2026.101942_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.752546","article-title":"NLRP3 Inflammasome: a new target for prevention and control of osteoporosis?","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12903-023-02827-0","article-title":"Oridonin alleviates the inhibitory effect of lipopolysaccharide on the proliferation and osteogenic potential of periodontal ligament stem cells by inhibiting endoplasmic reticulum stress and NF-\u03baB\/NLRP3 inflammasome signaling","volume":"23","author":"Jiang","year":"2023","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.bonr.2026.101942_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"12","author":"Kular","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bonr.2026.101942_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bonr.2026.101942_bb0085","article-title":"Oridonin: a review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bonr.2026.101942_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bonr.2026.101942_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.bonr.2026.101942_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10495-022-01807-z","article-title":"Pyroptosis in bone loss","volume":"28","author":"Li","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bonr.2026.101942_bb0105","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2147\/DDDT.S110125","article-title":"Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) \/J mice","volume":"10","author":"Liu","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"7","key":"10.1016\/j.bonr.2026.101942_bb0110","first-page":"1100","article-title":"Effect of oridonin on apoptosis of osteoblasts in osteoporotic rats by regulating hippo\/YAP signaling pathway","volume":"30","author":"LU Haifeng","year":"2024","journal-title":"Hebei Med."},{"issue":"3","key":"10.1016\/j.bonr.2026.101942_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4049\/jimmunol.1600659","article-title":"Hyperactivation of the NLRP3 inflammasome in myeloid cells leads to severe organ damage in experimental lupus","volume":"198","author":"Lu","year":"2017","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bonr.2026.101942_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101398","article-title":"The role of autophagy in osteoclast differentiation and bone resorption function","volume":"10","author":"Montaseri","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.bonr.2026.101942_bb0125","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1093\/rheumatology\/kead416","article-title":"Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus","volume":"62","author":"Nepal","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bonr.2026.101942_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4139048","article-title":"MCC950, the NLRP3 inhibitor, protects against cartilage degradation in a mouse model of osteoarthritis","volume":"2021","author":"Ni","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.bonr.2026.101942_bb0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bonr.2026.101942_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2021.105269","article-title":"Targeting the Nod-like receptor protein 3 inflammasome with inhibitor MCC950 rescues lipopolysaccharide-induced inhibition of osteogenesis in human periodontal ligament cells","volume":"131","author":"Peng","year":"2021","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bonr.2026.101942_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116679","article-title":"NLRP3 inflammasome and its role in autoimmune diseases: a promising therapeutic target","volume":"175","author":"Ren","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bonr.2026.101942_bb0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14336\/AD.2021.0617","article-title":"Pharmacological blockade of NLRP3 inflammasome\/IL-1\u03b2-positive loop mitigates endothelial cell senescence and dysfunction","volume":"1","author":"Romero","year":"2022","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0155","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1038\/s41598-019-46657-z","article-title":"LC3-positive structures are prominent in autophagy-deficient cells","volume":"9","author":"Runwal","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bonr.2026.101942_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1\u03b2 in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101942_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bonr.2026.101942_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109313","article-title":"Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"118","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bonr.2026.101942_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/385297","article-title":"Effect of proinflammatory cytokines (IL-6, TNF-\u03b1, and IL-1\u03b2) on clinical manifestations in Indian SLE patients","volume":"2014","author":"Umare","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.bonr.2026.101942_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11914-016-0318-z","article-title":"Osteonecrosis of the jaw-a bone site-specific effect of bisphosphonates","volume":"14","author":"Vermeer","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.12302","article-title":"Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system","volume":"266","author":"Walsh","year":"2015","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.bonr.2026.101942_bb0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2017.02.007","article-title":"NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation","volume":"484","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bonr.2026.101942_bb0200","article-title":"Exploring the relationship between pyroptosis and inflammatory bone loss: evidence from a cigarette smoke-induced osteoporosis mouse model","volume":"15","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.bonr.2026.101942_bb0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3334","article-title":"A novel diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting Ifrd1-mediated and I\u03baB\u03b1-mediated p65 nuclear translocation","volume":"33","author":"Xie","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2026.101942_bb0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bonr.2026.101942_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010132","article-title":"Regulation of TNF-induced osteoclast differentiation","volume":"11","author":"Yao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bonr.2026.101942_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110011","article-title":"Protective effects of oridonin against osteoporosis by regulating immunity and activating the Wnt3a\/\u03b2-catenin\/VEGF pathway in ovariectomized mice","volume":"118","author":"Yu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bonr.2026.101942_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112648","article-title":"Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3\/caspase-1\/GSDMD pathway","volume":"405","author":"Zhang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bonr.2026.101942_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112772","article-title":"Bisphenol A induces pyroptotic cell death via ROS\/NLRP3\/Caspase-1 pathway in osteocytes MLO-Y4","volume":"159","author":"Zhang","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bonr.2026.101942_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102515","article-title":"Recent advances in the NEK7-licensed NLRP3 inflammasome activation: mechanisms, role in diseases and related inhibitors","volume":"113","author":"Zhao","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bonr.2026.101942_bb0240","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.2147\/JIR.S437067","article-title":"The potential of natural compounds regulating autophagy in the treatment of osteoporosis","volume":"16","author":"Zhao","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"1\u20133","key":"10.1016\/j.bonr.2026.101942_bb0245","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2013.05.016","article-title":"Oridonin ameliorates lupus-like symptoms of MRL(lpr\/lpr) mice by inhibition of B-cell activating factor (BAFF)","volume":"715","author":"Zhou","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bonr.2026.101942_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118563","article-title":"Oridonin promotes osteogenesis through Wnt\/\u03b2-catenin pathway and inhibits RANKL-induced osteoclastogenesis in vitro","volume":"262","author":"Zhou","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bonr.2026.101942_bb0255","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.7150\/jca.55929","article-title":"Oridonin inhibits tumor angiogenesis and induces vessel normalization in experimental colon cancer","volume":"11","author":"Zhou","year":"2021","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.bonr.2026.101942_bb0260","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41401-020-0477-4","article-title":"Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression","volume":"42","author":"Zou","year":"2021","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235218722600046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235218722600046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:40:33Z","timestamp":1789544433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235218722600046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S235218722600046X"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101942","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of NLRP3 alleviates systemic lupus erythematosus-induced osteoporosis through dual modulation of osteogenesis and osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101942"}}